Annals of the Rheumatic Diseases: 80 (5)

Editorial

Vitamin K and osteoarthritis: is there a link? (12 April, 2021) Free
Richard F Loeser, Francis Berenbaum, Margreet Kloppenburg

Review

Anti-inflammatory therapy for COVID-19 infection: the case for colchicine (8 December, 2020)
Aaron Z Reyes, Kelly A Hu, Jacob Teperman, Theresa L Wampler Muskardin, Jean-Claude Tardif, Binita Shah, Michael H Pillinger

Rheumatoid arthritis

Large-scale meta-analysis across East Asian and European populations updated genetic architecture and variant-driven biology of rheumatoid arthritis, identifying 11 novel susceptibility loci (11 December, 2020)
Eunji Ha, Sang-Cheol Bae, Kwangwoo Kim
Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis (4 January, 2021)
Joshua F Baker, Bryant R England, Michael George, Grant Cannon, Brian Sauer, Alexis Ogdie, Bartlett C Hamilton, Carlos Hunter, Michael J Duryee, Geoffrey Thiele, Ted R Mikuls
Streptococcus species enriched in the oral cavity of patients with RA are a source of peptidoglycan-polysaccharide polymers that can induce arthritis in mice
(4 January, 2021)
Rabia Moentadj, Yiwen Wang, Kate Bowerman, Linda Rehaume, Hendrik Nel, Paraic O Cuiv, Juliette Stephens, Amalina Baharom, Muralidhara Maradana, Vanessa Lakis, Mark Morrison, Timothy Wells, Philip Hugenholtz, Helen Benham, Kim-Anh Le Cao, Ranjeny Thomas

Psoriatic arthritis

Secukinumab in patients with psoriatic arthritis and axial manifestations: results from the double-blind, randomised, phase 3 MAXIMISE trial (17 December, 2020)
Xenofon Baraliakos, Laure Gossec, Effie Pournara, Slawomir Jeka, Antonio Mera-Varela, Salvatore D'Angelo, Barbara Schulz, Michael Rissler, Kriti Nagar, Chiara Perella, Laura C Coates
IL-23 skin and joint profiling in psoriatic arthritis: novel perspectives in understanding clinical responses to IL-23 inhibitors (26 November, 2020)
Alessandra Nerviani, Marie-Astrid Boutet, Wang Sin Gina Tan, Katriona Goldmann, Nirupam Purkayastha, Tamas Ajtos Lajtos, Rebecca Hands, Myles Lewis, Stephen Kelly, Costantino Pitzalis

Osteoarthritis

Vitamin K antagonist anticoagulant usage is associated with increased incidence and progression of osteoarthritis (12 April, 2021)
Cindy G Boer, Ingrid Szilagyi, N Long Nguyen, Tuhina Neogi, Ingrid Meulenbelt, M Arfan Ikram, André G Uitterlinden, Sita Bierma-Zeinstra, Bruno H Stricker, Joyce B van Meurs
Warfarin use and risk of knee and hip replacements (12 April, 2021) Free
Priyanka Ballal, Christine Peloquin, Cindy Germaine Boer, Tuhina Neogi

Paediatric rheumatology

Geospatial clustering of childhood IgA vasculitis and IgA vasculitis-associated nephritis (18 November, 2020)
Matej Sapina, Marijan Frkovic, Mario Sestan, Sasa Srsen, Aleksandar Ovuka, Mateja Batnozic Varga, Karolina Kramaric, Dario Brdaric, Kresimir Milas, Alenka Gagro, Marija Jelusic
Monocyte and bone marrow macrophage transcriptional phenotypes in systemic juvenile idiopathic arthritis reveal TRIM8 as a mediator of IFN-γ hyper-responsiveness and risk for macrophage activation syndrome (4 December, 2020)
Grant S Schulert, Alex V Pickering, Thuy Do, Sanjeev Dhakal, Ndate Fall, Daniel Schnell, Mario Medvedovic, Nathan Salomonis, Sherry Thornton, Alexei A Grom
Association of novel rare coding variants with juvenile idiopathic arthritis (6 January, 2021)
Xinyi Meng, Xiaoyuan Hou, Ping Wang, Joseph T Glessner, Hui-Qi Qu, Michael E March, Sipeng Zhang, Xiaohui Qi, Chonggui Zhu, Kenny Nguyen, Xinyi Gao, Xiaoge Li, Yichuan Liu, Wentao Zhou, Shuyue Zhang, Junyi Li, Yan Sun, Jie Yang, Patrick M A Sleiman, Qianghua Xia, Hakon Hakonarson, Jin Li

Systemic lupus erythematosus

Meta-analysis of 208370 East Asians identifies 113 susceptibility loci for systemic lupus erythematosus (3 December, 2020)
Xianyong Yin, Kwangwoo Kim, Hiroyuki Suetsugu, So-Young Bang, Leilei Wen, Masaru Koido, Eunji Ha, Lu Liu, Yuma Sakamoto, Sungsin Jo, Rui-Xue Leng, Nao Otomo, Viktoryia Laurynenka, Young-Chang Kwon, Yujun Sheng, Nobuhiko Sugano, Mi Yeong Hwang, Weiran Li, Masaya Mukai, Kyungheon Yoon, Minglong Cai, Kazuyoshi Ishigaki, Won Tae Chung, He Huang, Daisuke Takahashi, Shin-Seok Lee, Mengwei Wang, Kohei Karino, Seung-Cheol Shim, Xiaodong Zheng, Tomoya Miyamura, Young Mo Kang, Dongqing Ye, Junichi Nakamura, Chang-Hee Suh, Yuanjia Tang, Goro Motomura, Yong-Beom Park, Huihua Ding, Takeshi Kuroda, Jung-Yoon Choe, Chengxu Li, Hiroaki Niiro, Youngho Park, Changbing Shen, Takeshi Miyamoto, Ga-Young Ahn, Wenmin Fei, Tsutomu Takeuchi, Jung-Min Shin, Keke Li, Yasushi Kawaguchi, Yeon-Kyung Lee, Yongfei Wang, Koichi Amano, Dae Jin Park, Wanling Yang, Yoshifumi Tada, Ken Yamaji, Masato Shimizu, Takashi Atsumi, Akari Suzuki, Takayuki Sumida, Yukinori Okada, Koichi Matsuda, Keitaro Matsuo, Yuta Kochi, Japanese Research Committee on Idiopathic Osteonecrosis of the Femoral Head, Leah C Kottyan, Matthew T Weirauch, Sreeja Parameswaran, Shruti Eswar, Hanan Salim, Xiaoting Chen, Kazuhiko Yamamoto, John B Harley, Koichiro Ohmura, Tae-Hwan Kim, Sen Yang, Takuaki Yamamoto, Bong-Jo Kim, Nan Shen, Shiro Ikegawa, Hye-Soon Lee, Xuejun Zhang, Chikashi Terao, Yong Cui, Sang-Cheol Bae

Systemic sclerosis

New composite endpoint in early diffuse cutaneous systemic sclerosis: revisiting the provisional American College of Rheumatology Composite Response Index in Systemic Sclerosis (30 November, 2020)
Dinesh Khanna, Suiyuan Huang, Celia J F Lin, Cathie Spino
Anti-centromere antibodies target centromere–kinetochore macrocomplex: a comprehensive autoantigen profiling (18 November, 2020)
Nobuhiko Kajio, Masaru Takeshita, Katsuya Suzuki, Yukari Kaneda, Humitsugu Yamane, Kazuhiro Ikeura, Hidekazu Sato, Shin Kato, Hiroyuki Shimizu, Kazuyuki Tsunoda, Tsutomu Takeuchi

Epidemiology

Coronavirus disease 2019 outcomes among patients with rheumatic diseases 6 months into the pandemic (30 November, 2020)
Naomi Serling-Boyd, Kristin M D’Silva, Tiffany YT Hsu, Rachel Wallwork, Xiaoqing Fu, Ellen M Gravallese, April M Jorge, Yuqing Zhang, Hyon Choi, Jeffrey A Sparks, Zachary S Wallace

Letters

Realising early recognition of arthritis in times of increased telemedicine: the value of patient-reported swollen joints (7 January, 2021)
Cleo Rogier, Bastiaan T van Dijk, Elisabeth Brouwer, Pascal H P de Jong, Annette H M van der Helm-van Mil
What comes after the lockdown? Clustering of ANCA-associated vasculitis: single-centre observation of a spatiotemporal pattern (1 December, 2020)
Philipp Gauckler, Erica L Bettac, Manfred Nairz, Christina Duftner, Anna K Luger, Markus Stein, David Wanner, Barbara C Böckle, Martin Tiefenthaler, Peter Schratzberger, Hannes Neuwirt, Lukas Harasser, Gert Mayer, Andreas Kronbichler
Prevalence, admission rates and hypoxia due to COVID-19 in patients with rheumatic disorders treated with targeted synthetic or biologic disease modifying antirheumatic drugs or methotrexate: a nationwide study from Iceland (5 January, 2021)
Aron Hjalti Bjornsson, Gerdur Grondal, Mar Kristjansson, Thorunn Jonsdottir, Thorvardur Jon Love, Bjorn Gudbjornsson
Declining in-hospital mortality gap between systemic lupus erythematosus (SLE) and non-SLE hospitalisations: a national study (10 November, 2020)
Jasvinder A Singh, John D Cleveland
The virtual fishbowl: bringing back dynamic debates to medical conferences (15 December, 2020)
Felix Muehlensiepen, Johanna Mucke, Martin Krusche, Sandra Kurkowski, Gerlinde Bendzuck, Ina Koetter, Vanessa Lemarié, Manuel Grahammer, Martin Heinze, Hendrik Schulze-Koops, Johannes Knitza

Electronic pages

COVID-19 in patients with rheumatological diseases treated with anti-TNF (16 June, 2020)
Carlos Antunes Brito, José Gerardo Paiva, Fernando Nunes Pimentel, Rosinete Santos Guimarães, Mariana Ribeiro Moreira
Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences (16 June, 2020)
Jun Zhao, Rongrong Pang, Jian Wu, Yanju Guo, Yang Yang, Libo Zhang, Xinyi Xia
Response to: ‘COVID-19 in patients with rheumatological diseases treated with Anti-TNF’ by Brito et al and ‘Clinical characteristics and outcomes of patients with COVID-19 and rheumatic disease in China ‘hot spot’ versus in US ‘hot spot’: similarities and differences’ by Zhao et al
(16 June, 2020)
Kristin M D’Silva, Naomi Serling-Boyd, Rachel Wallwork, Tiffany Hsu, Jeffrey A Sparks, Zachary Scott Wallace
Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic (25 June, 2020)
Pedro Santos-Moreno, Josefina Chavez-Chavez, Sandra Milena Hernández-Zambrano, Diana Patricia Rivera-Triana, Ruth Alexandra Castiblanco-Montañez, Anggie Aza, Diana Buitrago-Garcia, Laura Villarreal, Adriana Rojas-Villarraga
Response to: ‘Experience of telemedicine use in a big cohort of patients with rheumatoid arthritis during COVID-19 pandemic’ by Santos-Moreno et al
(25 June, 2020)
Emanuele Bozzalla Cassione, Giovanni Zanframundo, Alessandro Biglia, Veronica Codullo, Carlomaurizio Montecucco, Lorenzo Cavagna
Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab (26 June, 2020)
Hendrik Schulze-Koops, Klaus Krueger, Inka Vallbracht, Rebecca Hasseli, Alla Skapenko
Response to: ‘Increased risk for severe COVID-19 in patients with inflammatory rheumatic diseases treated with rituximab’ by Schulze-Koops et al
(26 June, 2020)
Sara Monti, Carlomaurizio Montecucco
COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine (31 July, 2020)
Cheng Lay Teh, Yaw Kiet Cheong, Wan Rosmaiza Wan Musa, Sharifah Aishah Wan Mohd Akbar, Noraini Mat Husin, Suk Chyn Gun
Response to: ‘COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine’ by Teh et al
(31 July, 2020)
Alexis Mathian, Zahir Amoura
Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India (15 July, 2020)
Mohit Goyal, Pravin Patil, Himanshu Pathak, Sham Santhanam, Anshul Goel, Vishnu Sharma, Akshat Pandey, Nikhil Gupta, Rahul Jain, Shashank Akerkar, Parthajit Das, Rajkiran Dudam, Naval Mendiratta, Bimlesh Dhar Pandey, Mithun CB, Bharat K Singh, Sharath Kumar, Nilesh Nolkha, Shriyanka Jain, Somya Jain, Ashish Sharma, Durga Prasanna Misra
Response to: ‘Impact of COVID-19 pandemic on patients with SLE: results of a large multicentric survey from India’ by Goyal et al
(15 July, 2020)
Alexis Mathian, Zahir Amoura
Presence of antiphospholipid antibodies in COVID-19: a case series study (4 August, 2020)
Luis M Amezcua-Guerra, Gustavo Rojas-Velasco, Malinalli Brianza-Padilla, Armando Vázquez-Rangel, Ricardo Márquez-Velasco, Francisco Baranda-Tovar, Rashidi Springall, Hector Gonzalez-Pacheco, Yaneli Juárez-Vicuña, Claudia Tavera-Alonso, Fausto Sanchez-Muñoz, Marisol Hernández-Salas
Response to: ‘Presence of anti-phospholipid antibodies in COVID-19: a case series study’ by Amezcua-Guerra et al
(4 August, 2020)
Alexis Mathian, Marc Pineton De Chambrun, Alain Combes, Zahir Amoura
Role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients (19 June, 2020)
Ennio Giulio Favalli, Orazio De Lucia, Martina Biggioggero, Nicoletta Del Papa, Roberto Caporali
Response to: ‘The role of antimalarials in COVID-19: observational data from a cohort of rheumatic patients’ by Favalli et al
(19 June, 2020)
Vasco C Romão, Ana Rita Cruz-Machado, João Eurico Fonseca
Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus (5 August, 2020)
Yasushi Kondo, Yuko Kaneko, Tatsuhiro Oshige, Hiroyuki Fukui, Shuntaro Saito, Mikio Okayama, Hirofumi Kamata, Makoto Ishii, Naoki Hasegawa, Koichi Fukunaga, Tsutomu Takeuchi
Response to: ‘Exacerbation of immune thrombocytopenia triggered by COVID-19 in patients with systemic lupus erythematosus’ by Kondo et al
(5 August, 2020)
Alexis Mathian, Zahir Amoura
Correspondence on ‘Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a patient with COVID-19 with psoriatic arthritis receiving ustekinumab’ (18 August, 2020)
Francesco Messina, Francesca Pampaloni, Stefano Piaserico
Response to: ‘Correspondence on Recovery from COVID-19 in a patient with spondyloarthritis treated with TNF-alpha inhibitor etanercept. A report on a COVID-19 patient with psoriatic arthritis receiving ustekinumab’ by Messina et al
(18 August, 2020)
Pierre-Marie Duret, Lionel Spielmann, Laurent Messer
Correction: Potential involvement of IL-22 and IL-22-producing cells in the inflamed salivary glands of patients with Sjogren’s syndrome
(12 April, 2021)
Correction: Transcutaneous auricular vagus nerve stimulation reduces pain and fatigue in patients with systemic lupus erythematosus: a randomised, double-blind, shame-controlled pilot trial
(12 April, 2021)
Correction: Safety profile of upadacitinib in rheumatoid arthritis: integrated analysis from the SELECT phase III clinical programme
(12 April, 2021)
Correction: Methotrexate and BAFF interaction prevents immunization against TNF inhibitors
(12 April, 2021)

Main menu

Table of contents

May 2021 - Volume 80 - 5

Editorial

Review

Rheumatoid arthritis

Psoriatic arthritis

Osteoarthritis

Paediatric rheumatology

Systemic lupus erythematosus

Systemic sclerosis

Epidemiology

Letters

Electronic pages

Issue Information

Log in using your username and password

Main menu

Log in using your username and password

You are here

Table of contents

May 2021 - Volume 80 - 5

Editorial

Review

Rheumatoid arthritis

Psoriatic arthritis

Osteoarthritis

Paediatric rheumatology

Systemic lupus erythematosus

Systemic sclerosis

Epidemiology

Letters

Electronic pages

Issue Information